Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
pemetrexed disodium hemipentahydrate, Quantity: 604.1 mg (Equivalent: pemetrexed, Qty 500 mg)
Interpharma Pty Ltd
Injection, concentrated
Excipient Ingredients: trometamol; hydrochloric acid; sodium hydroxide; water for injections; monothioglycerol; citric acid
Intravenous Infusion
1 vial
(S4) Prescription Only Medicine
Malignant Pleural Mesothelioma,PEMETREXED EVER PHARMA, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer,PEMETREXED EVER PHARMA in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.,PEMETREXED EVER PHARMA as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy.
Visual Identification: Clear, slighlty yellow to green-yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Registered
2022-10-25
InterPharma Pemetrexed Ever Pharma CMI V1.1 Oct 2022 Page 1 of 5 PEMETREXED EVER PHARMA CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING PEMETREXED EVER PHARMA? PEMETREXED EVER PHARMA contains the active ingredient pemetrexed_ _disodium hemipentahydrate. PEMETREXED EVER PHARMA is used to TREAT mesothelioma, a rare cancer of the lungs often related to exposure to asbestos and non-small cell lung cancer, a type of lung cancer. For more information, see Section 1. Why am I using PEMETREXED EVER PHARMA? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE PEMETREXED EVER PHARMA? Do not use if you have ever had an allergic reaction to PEMETREXED EVER PHARMA or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use PEMETREXED EVER PHARMA? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with PEMETREXED EVER PHARMA and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE PEMETREXED EVER PHARMA? Pemetrexed is given as an infusion (drip) into your veins over a 10 minute period. Pemetrexed is given once every three weeks (1 treatment cycle). Your doctor will advise how many treatment cycles you need. More instructions can be found in Section 4. How do I use PEMETREXED EVER PHARMA? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING PEMETREXED EVER PHARMA? THINGS YOU SHOULD DO Remind any doctor, dentist or pharmacist you visit that you are using PEMETREXED EVER PHARMA. Always take your daily folate supplement until your doctor tells you to stop. Always check with your doctor that your vitamin B12 injections are up to date Keep all of your doctor's appoin Прочитать полный документ
InterPharma Pemetrexed Ever Pharma PI V1.8 Oct 2022 Page 1 of 25 AUSTRALIAN PRODUCT INFORMATION PEMETREXED EVER PHARMA (PEMETREXED DISODIUM HEMIPENTAHYDRATE) CONCENTRATED SOLUTION FOR INJECTION 1. NAME OF THE MEDICINE Pemetrexed disodium hemipentahydrate. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION PEMETREXED EVER PHARMA is supplied as a sterile concentrated solution for injection of pemetrexed (as disodium hemipentahydrate) 25 mg/mL in vials in three volumes 100 mg in 4 mL 500 mg in 20 mL 1000 mg in 40 mL For the full list of excipients, see section 6.1 LIST OF EXCIPIENTS. 3. PHARMACEUTICAL FORM PEMETREXED EVER PHARMA is an aqueous, clear, slightly yellow to green-yellow concentrate for solution for infusion with a pH of 7.5 – 8.1 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS MALIGNANT PLEURAL MESOTHELIOMA PEMETREXED EVER PHARMA, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma. NON-SMALL CELL LUNG CANCER PEMETREXED EVER PHARMA in combination with cisplatin is indicated for initial treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. PEMETREXED EVER PHARMA as monotherapy is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology after prior platinum-based chemotherapy. InterPharma Pemetrexed Ever Pharma PI V1.8 Oct 2022 Page 2 of 25 4.2 DOSE AND METHOD OF ADMINISTRATION PEMETREXED EVER PHARMA should be administered under the supervision of a qualified physician experienced in the use of antineoplastic agents. PEMETREXED EVER PHARMA in combination use with cisplatin: Adults - The recommended dose of PEMETREXED EVER PHARMA is 500 mg/m 2 as body surface area (BSA) administered as an intravenous infusion over 10 minutes on the first day of each 21 day cycle. The recommended dose of cisplatin is 75 mg/m 2 BSA infused over 2 hours approximately 30 minutes after completion of Прочитать полный документ